ABIOMED, Inc. (ABMD) - Product Pipeline Analysis

Document Sample
ABIOMED, Inc. (ABMD)  - Product Pipeline Analysis Powered By Docstoc
					                                        ABIOMED, Inc. (ABMD) - Product Pipeline Analysis

     Reference Code: GDME841PD                                                                                          Publication Date: NOV 2010



    Company Snapshot                                                  Company Overview
    Key Information
                                                                      ABIOMED, Inc. (Abiomed) is a global technology company, engaged in
     ABIOMED, Inc., Key Facts                                         providing medical devices in circulatory support that offer a continuum of
                                                                      care in heart recovery of acute heart failure patients. The company’s
     Web Address                            www.abiomed.com
                                                                      products are designed to improve blood flow and to perform the pumping
     Turnover (in USD Million) 85.70                                  function of the heart to permit the heart to rest, heal and recover. Abiomed
                                                                      operates in the US, Europe, Australia, China, Italy, Japan, Latin America
     Number of Employees                    365                       and Middle East. The company is headquartered in Massachusetts, the US.
     Industry                               Pharmaceuticals and
                                            Healthcare-
     Source:Primary / Secondary Research
     GlobalData



    ABIOMED, Inc. Pipeline Products

     ABIOMED, Inc. Key Pipeline Products by Equipment                 ABIOMED, Inc. Key Pipeline Products by Therapy Area
     Type
     Equipment Type                         No of Products            Therapy Area                                                No of Products
     Cardiac Assist Devices                      6                    Acute myocardial infarction                                    2
     Interventional Cardiology                                    1   Acute heart failure, Cardiogenic shock                         1
     Cardiovascular Prosthetic Devices                            1   Biventricular end stage heart failure                          1
                                                                      Cardiomyopathy, Congestive heart failure,                      1
                                                                      Myocardial infarction
                                                                      Heart failure                                                  1
                                                                      Left ventricular dysfunction                                   1
     Source: Primary / Secondary Research
                                                                      Source: Primary / Secondary Research
     GlobalData
                                                                      GlobalData


     ABIOMED, Inc. Key Pipeline Products by Equipment Type




     Source: Primary / Secondary Research
     GlobalData




     ABIOMED, Inc. Key Pipeline Products by Development               ABIOMED, Inc. Key Pipeline Products by Trial Phase
     Stage
     Developmental Stage                    No of Products            Trial Phase                                                 No of Products
     Clinicals                               7                        Phase IV                                                -
     Pre-Clinicals                                           -        Phase III                                               1
     Early development                                       -        Phase II                                                1
     Source: Primary / Secondary Research                             Phase I                                                 -
     GlobalData
                                                                      Source: Primary / Secondary Research
     Note : (-) indicates 'Not Available'
                                                                      GlobalData
                                                                      Note : (-) indicates 'Not Available'




ABIOMED, Inc. (ABMD) - Product Pipeline Analysis                                                                              Reference Code: GDME841PD

Source : www.globalcompanyintelligence.com                                                                                                           Page 1
    Table of Contents
    Table of Contents................................................................................................................................................................................................................................................................... 2
    List of Tables .......................................................................................................................................................................................................................................................................... 3
    List of Figures......................................................................................................................................................................................................................................................................... 4
    ABIOMED, Inc. - Business Description .................................................................................................................................................................................................................................. 5
    Key Facts ............................................................................................................................................................................................................................................................................... 6
    ABIOMED, Inc. - Major Products and Services...................................................................................................................................................................................................................... 7
          ABIOMED, Inc. Pipeline Products by Equipment Type ................................................................................................................................................................................................... 8
          ABIOMED, Inc. Pipeline Products by Development Stage ............................................................................................................................................................................................ 10
          ABIOMED, Inc. Pipeline Products by Therapy Area...................................................................................................................................................................................................... 12
          ABIOMED, Inc. Pipeline Products by Trial Phase ......................................................................................................................................................................................................... 14
          Abiocor........................................................................................................................................................................................................................................................................... 16
                Product Status......................................................................................................................................................................................................................................................... 16
                Product Description ................................................................................................................................................................................................................................................. 16
                Product Milestone ................................................................................................................................................................................................................................................... 16
                Abiocor Clinical Trial ............................................................................................................................................................................................................................................... 17
                Product Patent Details ............................................................................................................................................................................................................................................ 17
          AbioCor II....................................................................................................................................................................................................................................................................... 18
                Product Status......................................................................................................................................................................................................................................................... 18
                Product Description ................................................................................................................................................................................................................................................. 18
                Product Milestone ................................................................................................................................................................................................................................................... 18
                Product Patent Details ............................................................................................................................................................................................................................................ 18
          Impella LP 2.5 - PCI....................................................................................................................................................................................................................................................... 19
                Product Status......................................................................................................................................................................................................................................................... 19
                Product Description ................................................................................................................................................................................................................................................. 20
                Product Milestone ................................................................................................................................................................................................................................................... 20
                Impella LP 2.5 - PCI Clinical Trial ........................................................................................................................................................................................................................... 21
          IMPELLA LP/LD 5.0 Support System ............................................................................................................................................................................................................................ 23
                Product Status......................................................................................................................................................................................................................................................... 23
                Product Description ................................................................................................................................................................................................................................................. 23
          Impella Pediatric Pump.................................................................................................................................................................................................................................................. 23
                Product Status......................................................................................................................................................................................................................................................... 23
                Product Description ................................................................................................................................................................................................................................................. 23
          Impella RP ..................................................................................................................................................................................................................................................................... 24
                Product Status......................................................................................................................................................................................................................................................... 24
                Product Description ................................................................................................................................................................................................................................................. 24
                Product Milestone ................................................................................................................................................................................................................................................... 24
          Integrated Cannula System ........................................................................................................................................................................................................................................... 25
                Product Status......................................................................................................................................................................................................................................................... 25
                Product Description ................................................................................................................................................................................................................................................. 25
                Product Milestone ................................................................................................................................................................................................................................................... 25
                Product Patent Details ............................................................................................................................................................................................................................................ 26
    ABIOMED, Inc. - Key Competitors ....................................................................................................................................................................................................................................... 27
    ABIOMED, Inc. - Key Employees......................................................................................................................................................................................................................................... 28
    ABIOMED, Inc. - Key Employee Biographies ...................................................................................................................................................................................................................... 29
    ABIOMED, Inc. - Locations And Subsidiaries ...................................................................................................................................................................................................................... 30
          Head Office......................................................................................................................................................................
				
DOCUMENT INFO
Description: ABIOMED, Inc. (ABMD) - Product Pipeline Analysis Summary This report is a source for data, analysis and actionable intelligence on the ABIOMED, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Scope - Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments. - Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase. - Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date. - Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application. - Data on relevant clinical trials and product patent details, wherever applicable. - Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility. Reasons to Buy
BUY THIS DOCUMENT NOW PRICE: $750 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.